Nuhant; Philippe Marcel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nuhant; Philippe Marcel.The latest application filed is for "n-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors".
- Nuhant; Philippe Marcel - Dorchester MA
| Patent | Date |
|---|---|
| N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides Useful As Ccr6 Inhibitors App 20210206757 - Gerstenberger; Brian Stephen ; et al. | 2021-07-08 |
| Modulators Of Alpha-1 Antitrypsin App 20210179587 - BANDARAGE; Upul Keerthi ; et al. | 2021-06-17 |
| N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Grant 10,975,065 - Gerstenberger , et al. April 13, 2 | 2021-04-13 |
| Modulators Of Alpha-1 Antitrypsin App 20200361939 - BANDARAGE; Upul Keerthi ; et al. | 2020-11-19 |
| N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides Useful As Ccr6 Inhibitors App 20200095239 - Gerstenberger; Brian Stephen ; et al. | 2020-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 